Abstract:Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) in non-lean patients is significantly increased, and obesity significantly increases the risk of cirrhosis and HCC in NAFLD patients. However, whether there is a difference in clinical manifestations of NAFLD between overweight and obesity remains unclear. The objective of this study was to assess the clinical and histological features of NAFLD amongst a non-lean population. Methods: Current study enrolled consecutive non-lean (body mass index (BMI)>23 kg/m2) patients with NAFLD and available liver biopsy results. Patients were stratified by BMI into two groups for the comparison of their clinical and histological variables, which included the overweight (BMI 23(similar to)<28 kg/m2) and the obese (BMI >= 28 kg/m2). Risk factors for moderate to severe fibrosis (stage>1) were also analyzed through the logistic regression model. Results: Among 184 non-lean patients with MALFD enrolled,65 and 119 were overweight and obese, respectively. Patients in the obesity group had a significantly lower level of gamma-glutamyl transpeptidase (GGT), higher levels of platelet (PLT), glucose (Glu), prothrombin time (PT), and more common of moderate to severe inflammatory activity when compared to those in the overweight group. However, a significant low frequency of moderate to severe fibrosis was found in the obesity group vs the overweight group (19.33% vs 40.00%, P=0.002). Binary logistics regression analysis of fibrosis found that aspartate transaminase (AST), BMI, alanine transaminase (ALT) and cholesterol (CHOL) were independent predictors for moderate to severe fibrosis in non-lean patients with NAFLD. Compared with the traditional FIB-4 (AUC=0.77) and APRI (AUC=0.79) indexes, the combined index based on AST, BMI, ALT and CHOL was more accurate in predicting moderate to severe fibrosis in non-lean patients with NAFLD (AUC=0.87). Conclusions: Clinical and histological features differed between obesity and overweight patients with NAFLD. When compared to the traditional serum markers, the combination index including AST, BMI, ALT and CHOL provided a better model to predict moderate to severe fibrosis in non-lean patients with NAFLD.

Metabolic and Histological Features of Non‐alcoholic Fatty Liver Disease Patients with Different Serum Alanine Aminotransferase Levels

Relationship Between Alanine Aminotransferase Levels and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

Ratio Of Conjugated Chenodeoxycholic To Muricholic Acids Is Associated With Severity Of Nonalcoholic Steatohepatitis

Study on the Relationship between Phospholipids and Nonalcoholic Fatty Liver Disease

Compare the Prevalence of Metabolic Abnormalities in the Patients with Fatty Liver or Elevated Alanine Aminiotransferase

General Characteristics and Clinical Practices of Chinese Patients with Non-Alcoholic Fatty Liver Disease

Lower Alanine Aminotransferase Levels Are Associated with Increased All-Cause and Cardiovascular Mortality in Nonalcoholic Fatty Liver Patients.

Increased hemoglobin and thrombocytocrit in non-alcoholic fatty liver disease

Association of Nonalcoholic Fatty Liver Disease with Type 2 Diabetes: Clinical Features and Independent Risk Factors in Diabetic Fatty Liver Patients.

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease

Association of the Frequency of Peripheral Natural Killer T Cells with Nonalcoholic Fatty Liver Disease

Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population.

The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease

Study on liver histopathology of chronic HBV infected patients with different normal ALT values

Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria

Alanine Aminotransferase-Old Biomarker and New Concept: A Review

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease